Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Share News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 536.00
Bid: 534.00
Ask: 538.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.749%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 536.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bloomsbury Publishing Sees First Quarter Revenues Down 9%

Thu, 10th Jul 2014 07:55

LONDON (Alliance News) - Bloomsbury Publishing PLC said Thursday its revenue in the first quarter to end-May was down 9% compared to the previous year, due to a weaker performance from its adult division.

The company saw growth in its academic and professional, children's and education divisions, but the adult division declined in comparison to the previous-year quarter, which Bloomsbury said had seen "exceptional success" with some books.

Best selling titles included Khaled Hosseini's 'And the Mountains Echoed' and Roz Ghast's 'Can't We Talk About Something More Pleasant?' in the adult division, and J.K Rowling's Harry Potter Box Set and John Green's 'Paper Towns' in children's and education.

Digital sales made up 12% of the company's total revenue for the period, up from 11%.

The company noted that the quarter traditionally generates its smallest profits of the year.

In the academic and professional division, Bloomsbury plans to launch online e-book collections for libraries, Bloomsbury Collections, in September. It launched its online information resource IZA World of Labor in May.

Bloomsbury said that the development of its online knowledge hubs is now a core part of its business as a result of the growing digital market, which means it has increased its investment in these platforms.

As a result, it has opted to include the amortisation of product and system development assets into its pretax profit, excluding highlighted items going forward. This will not affect its pretax profit or cash, but will mean its results for the previous fiscal year will be restated to reduce pretax profit excluding highlighted items by GBP1.0 million.

As at June 30 the company had net cash of GBP2.9 million, down from GBP8.5 million, due to acquisition costs.

"We remain well positioned to benefit from a strong publishing programme, including powerful new titles from Margaret Atwood, Paul Hollywood and Tom Kerridge later this year," said Chief Executive Nigel Newton in a statement.

Shares in Bloomsbury were trading down 5.1% at 166.00 pence Thursday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
26 Mar 2018 21:56

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 07:23

UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success

ZURICH, March 26 (Reuters) - Roche's immunotherapy Tecentriq combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss trial

Read more
25 Mar 2018 14:15

Israel to launch Big Data health project

By Maayan Lubell JERUSALEM, March 25 (Reuters) - Israel will invest nearly 1 billion shekels ($287 million) in a to a

Read more
20 Mar 2018 07:05

UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer

ZURICH, March 20 (Reuters) - Roche's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in advanced squamous lung cancer, but it did not

Read more
19 Mar 2018 17:59

Bloomsbury Publishing Expecting Profitability To Beat Expectations

LONDON (Alliance News) - Bloomsbury Publishing PLC said on Monday it expects its full-year profit and revenue to both be ahead of expectations.For the year ending 28 to

Read more
20 Jan 2017 09:08

Bloomsbury Publishing Says Chairman Salz To Step Down In July

Read more
27 Oct 2016 07:43

Bloomsbury Publishing Sees Stronger Second Half As Trading In Line

Read more
13 Jul 2016 12:55

Bloomsbury Publishing plots expansion into B2B market

(ShareCast News) - Harry Potter publisher Bloomsbury Publishing held a capital markets day for investors and analysts on Wednesday to present plans to enter the business-to-business market, while also confirming first-quarter trading remained in line with full year expectations. Bloomsbury unveiled

Read more
13 Jul 2016 08:20

Bloomsbury Publishing Says Full Year Trading To Meet Expectations

Read more
12 Jul 2016 15:11

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Jul 2016 15:00

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 May 2016 12:43

Bloomsbury moves towards digital B2B after strong FY

(ShareCast News) - Bloomsbury, the publisher behind the Harry Potter phenomenon, has turned in an overall strong set of full-year results and launched a 2020 strategy to move into digital B2B publishing. It booked a full-year pretax profit of £10.36m, from a year-earlier profit of £9.60m, with reven

Read more
19 May 2016 08:18

Bloomsbury To Reoganise Divisions As Profit Lifted By Children's Books

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.